India In-Vitro Diagnostics (IVD) Industry: Mounting the Next Evolution Trajectory

New York, USA, 2018-Dec-07 — /EPR Network/ — According to Goldstein Research, significant upsurge in automation, higher penetration of insurance cover, rapid urbanization, increasing number of laboratories, mounting consolidation, health awareness, and improvement in medical infrastructure are the major factors responsible for the growth. Moreover, the government is also increasing public expenditure in healthcare from just 1% to 2.5% of GDP. India In-Vitro Diagnostics Market outlook also includes new business models, product developments and capital investment as the key strategies adopted by the major players for significant expansion of business in the country.The molecular diagnostics products market is growing swiftly as they possess higher accuracy and allow for quick detection of infectious diseases and genetic disorders at an initial stage of development. However,lack of proper reimbursement system around the globe is the major concern for the in-vitro diagnostics market.

Browse Full Report:

Market Segmentation

On the basis of our in-depth analysis, India In-Vitro diagnostics market can be segmented as follows:

Based on Healthcare Segments

  • By Immunochemistry
  • By Clinical Chemistry
  • By Hematology
  • By Global Anticoagulation Therapy Market & Hemostasis
  • By Clinical Microbiology
  • By Molecular Diagnostics
  • By Biochemistry
  • By Others

Based on Application

  • Oncology
  • Diabetes
  • Infectious Disease
  • Cardiology
  • Autoimmune Disease
  • Nephrology
  • Drug Testing
  • Others

Based on End User

  • Hospitals
  • Diagnostics/Pathology Labs
  • Research and Development Centers (R&D)
  • Home care Settings

India In-Vitro-Diagnostics Market Reportcontains detailed overview of the India In-Vitro-Diagnostics market. On the basis of our in-depth analysis, market can be segmented in terms of market segmentation by display, by resolution, by screen size, by distribution channel and by end users.

Download Exclusive Sample Report:

 Further, for the in-depth analysis, India In-Vitro-Diagnostics Market Analysis encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis. This market report also includes competitive outlook of some of the major players profiling of companies such as Roche Diagnostics, Beckman Coulter, Siemens, Transasia Bio-Medicals Ltd., Accurex, Bayer Healthcare, Becton and Dickinson and bioMerieux etc.

The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments. Overall, the report represents the India In-Vitro-Diagnostics market trends along with market forecast that will help industry consultants, technology providers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.

India IVD Diagnostics Market is driving on the basis of advancement in the mentioned below industries:

Global Allergy Diagnostics Market

According to Goldstein Research, Allergy Diagnostics Market is anticipated to grow at 12.74% CAGR over the forecast period 2017-2025. The factors such as the high rate of prevalence of disease and the presence of world-class allergy diagnosis facilities are propelling the growth of the allergy diagnostics market.The growth of EEG Devices Market is primarily driving the growth of the market.

Point of Care Diagnostics Market

Point of care diagnostics (POCD) is a rapid detection of analytes nearby the patient. This facilitates the disease diagnosis, management and monitoring. Point of Care Diagnostics Market is expected to grow at a CAGR of 9.3% over the forecast period (2017-2025). North America has largest market for POCD on the back of huge healthcare expenditure in the region followed by Europe

Anticoagulation Therapy Market

Novel Oral Anticoagulants (NOACs) have major pharmacologic benefits over warfarin, which is a vitamin K antagonist, together with the rapid onset/offset of action, few drug interactions and predictable pharmacokinetics. The Anticoagulation Therapy Market is expected to reach USD 31.4 billion by 2025, growing at a CAGR of 8.01% during the forecast period.  North America accounted for the largest market share of anticoagulation therapy market owing to rising number of the hospital associated clinics and high healthcare expenditure. The US Anticoagulation Therapy Market is expected to reach USD 12.56 billion by 2025, growing at a CAGR of 7.87% during the forecast period

Liquid Biopsy Market

A biopsy is a test conducted by surgeon, cardiologist or radiologist which involves withdrawal of certain cell or tissues to examine the existence of some disease in the body.Global liquid biopsy market is an emerging market globally and will show an exponential growth in six to seven years. Liquid Biopsy Market was valued at USD 635.25 million in 2016, and is estimated to reach USD 3.85 billion by 2024, registering a CAGR of 28.9% from 2016 to 2024.

Matched content

Editor’s pick